Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMYT | DSGN | REPL | ||
| Company | Amryt Pharma Plc ADR | Design Therapeutics Inc | Replimune Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.71 | 15.31 | 11.18 | ||
| High | 14.76 | 15.74 | 11.32 | ||
| Low | 14.63 | 14.93 | 10.90 | ||
| Latest | 14.70 | 15.42 | 11.11 | ||
| Change | +0.01 | +0.14 | -0.01 | ||
| % Change | +0.07% | +0.92% | -0.09% | ||
| Volume | 2,389,400 | 644,000 | 2,743,800 | ||
| 20-Day Average Volume | 650,490 | 1,023,660 | 3,130,110 | ||
| Previous Close | 14.69 | 15.28 | 11.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.59 | 13.28 | 10.54 | ||
| 20-Day Raw Stochastic | 75.00% | 92.07% | 67.29% | ||
| 20-Day Relative Strength | 72.77 | 64.54 | 64.28 | ||
| Weighted Alpha | +10.40 | +279.14 | +93.89 | ||
| Today's Opinion | 88% Buy | 100% Buy | 72% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 96% Buy | 24% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.62% since 04/03/23 | +5.18% since 07/01/26 | -0.98% since 07/01/26 | ||
| Low | 14.58 on 04/04/23 | 14.22 on 07/02/26 | 10.84 on 07/08/26 | ||
| High | 14.76 on 04/11/23 | 15.86 on 07/06/26 | 11.95 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +0.62% since 03/10/23 | +46.16% since 06/09/26 | +20.24% since 06/09/26 | ||
| Low | 14.52 on 03/16/23 | 10.31 on 06/11/26 | 8.25 on 06/11/26 | ||
| High | 14.76 on 04/11/23 | 15.86 on 07/06/26 | 12.50 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | -0.47% since 01/11/23 | +23.46% since 04/09/26 | +87.99% since 04/09/26 | ||
| Low | 14.52 on 03/16/23 | 9.87 on 06/02/26 | 1.50 on 04/13/26 | ||
| High | 14.77 on 01/13/23 | 17.25 on 04/29/26 | 12.50 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +116.18% since 10/11/22 | +64.22% since 01/09/26 | +38.36% since 01/09/26 | ||
| Low | 6.50 on 10/28/22 | 8.82 on 01/13/26 | 1.50 on 04/13/26 | ||
| High | 14.77 on 01/13/23 | 17.25 on 04/29/26 | 12.50 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 940,256 | 954,343 | 933,468 | ||
| Shares Outstanding, K | 63,963 | 62,457 | 83,945 | ||
| Annual Sales | 222,540,000 | 0 | 0 | ||
| Annual Net Income | 1,000,000 | -69,790,000 | -313,940,000 | ||
| Last Quarter Sales | 61,126,000 | 0 | 0 | ||
| Last Quarter Net Income | -20,795,000 | -17,640,000 | -73,220,000 | ||
| 60-Month Beta | 0.84 | 1.58 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/03/22 | -0.29 on 04/28/26 | -0.76 on 06/29/26 | ||
| Earnings Date | 05/03/23 | 08/06/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 734.50 | 0.00 | 0.00 | ||